| Publication | Nature of Publication | Date |
| How can A&E units improve their performance? (link) | Guest blog written by Barbara for 2020health think tank. | January 2015 |
| Hospital inspections: lessons to be learnt (link) | Guest blog written by Barbara for 2020health think tank. | December 2014 |
| Threats to Mankind from Drug Resistant Bacteria and Viruses (link) | Guest blog written by Barbara for 2020health think tank. | August 2014 |
| Are pharmaceutical mega-mergers in the public interest? (link) | Guest blog written by Barbara for 2020health think tank. | May 2014 |
| Medical advisory body “NICE” should not spend too much time valuing drugs (link) | Guest blog written by Barbara for 2020health think tank. | April 2014 |
| Negotiations with the UK Government over pharmaceutical pricing have achieved a good result for patients, the NHS and the industry (link) | Guest blog written by Barbara for 2020health think tank. | December 2013 |
| Pharmaceutical companies must be free to determine their own research priorities: Lessons from Alzheimer’s Disease (link) | Guest blog written by Barbara for 2020health think tank. | October 2013 |
| Pharmaceutical Industry - Innovation is the only way forward (link) | Guest blog written by Barbara for 2020health think tank. | August 2013 |
| Value-based pricing: the wrong medicine for the nation? (link) | Report from 2020health think tank with Barbara as main author. | May 2013 |
| Waiting for Decisions on UK Pharmaceutical Pricing (link) | Guest blog written by Barbara for 2020health think tank. | April 2013 |
| Response to Department of Health Consultation on NHS Constitution (link) | Submission to Department of Health in response to consultation document. | January 2013 |
| Prevention is better than cure (link) | Guest blog written by Barbara for 2020health think tank. | January 2013 |
| Health and Social Care Act 2012: Response to Attacks on the Act (link) | Article published on this website. | November 2012 |
| The NHS Constitution - the turning point? (link) | Guest blog written by Barbara for 2020health think tank. | November 2012 |
| Think carefully about value-based drug pricing in the UK and let common sense prevail (link) | Guest blog written by Barbara for 2020health think tank. | September 2012 |
| Do private patients in the UK help or harm the NHS? (link) | Guest blog written by Barbara for 2020health think tank. | September 2012 |
| The Pharmaceutical Industry – Friend or Foe? (link) | Guest blog written by Barbara for 2020health think tank. | July 2012 |
| Response to HM Treasury Consultation on an 'above the line' credit for Research and Development (R&D) (link) | Submission to HM Treasury in response to consultation document. |
June 2012 |
| Management Priorities in the NHS under the Health and Social Care Act (link) | Guest blog written by Barbara for 2020health think tank. | June 2012 |
|
A wrong decision on UK drug pricing could seriously undermine all the good work that HM Treasury and the Department for Business, Innovation and Skills have done to encourage the UK pharmaceutical industry (link) | Guest blog written by Barbara for 2020health think tank. | May 2012 |
| The NHS needs outstanding management as well as a legal framework, for example, to unlock the potential of the property portfolio (link) | Guest blog written by Barbara for 2020health think tank. |
April 2012 |
| Pharmaceutical R & D – the value of radical innovation versus incremental progress (link) | Guest blog written by Barbara for 2020health think tank. | March 2012 |
| The Health and Social Care Bill: Final Stages in Parliament (link) |
Guest blog written by Barbara for 2020health think tank. | February 2012 |
| Misleading, Biased Reporting on the Health and Social Care Bill in the Media (link) | Guest blog written by Barbara for 2020health think tank. | January 2012 |
| Political Mood Change over the NHS, Innovation and the Pharmaceutical Industry in 2011 (link) | Guest blog written by Barbara for 2020health think tank. |
December 2011 |
| Parallel importing and exporting of pharmaceuticals severely limits the options in designing an effective UK drug pricing scheme (link) | Guest blog written by Barbara for 2020health think tank. | November 2011 |
| The highest standards of medical care urgently require doctors to remain up to date through Continuing Professional Development (link) | Guest blog written by Barbara for 2020health think tank. | October 2011 |
| What should we expect from medical and pharmaceutical R&D in the future? (link) | Guest blog written by Barbara for 2020health think tank. | September 2011 |
| The Patent Box (link) | Submission to HM Treasury in response to Further Consultation. | September 2011 |
| Research and Development Tax Credits (link) | Submission to HM Treasury in response to Further Consultation. | September 2011 |
| Contribution to Debate on UK Pharmaceutical Pricing (link) | Defence of PPRS in response to article criticising it. | August 2011 |
| Is it possible for NICE to be objective about pharmaceutical pricing? (link) | Guest blog written by Barbara for 2020health think tank. | August 2011 |
| The UK Government’s Latest Thinking on the Value-Based Pricing of Medicines (link) | Guest blog written by Barbara for 2020health think tank. | July 2011 |
| NHS Reforms - What the UK Government Policy Changes Really Mean (link) | Guest blog written by Barbara for 2020health think tank. | June 2011 |
| The UK Needs More Biotechnology Companies (link) | Guest blog written by Barbara for 2020health think tank. | May 2011 |
| The Future of Pharmaceutical R&D (link) | Guest blog written by Barbara for 2020health think tank. |
April 2011 |
| A new value-based approach to the pricing of branded medicines: a consultation (link) | Submission to Department of Health in response to Consultation. | March 2011 |
| Dept. of Health Consultation on Drug Pricing: “A new value-based approach to the pricing of branded medicines” (link) |
Guest blog written by Barbara for 2020health think tank. | March 2011 |
| Response to HM Treasury Informal Consultation on R&D Tax Credits (link) | Submission to HM Treasury in response to consultation document. | February 2011 |
| Response to HM Treasury Informal Consultation on the Patent Box (link) | Submission to HM Treasury in response to consultation document. | February 2011 |
| How to encourage pharmaceutical R&D ( link) | Guest blog written by Barbara for 2020health think tank. | February 2011 |
| NHS Reforms: Health and Social Care Bill 2011 (link) | Guest blog written by Barbara for 2020health think tank. | January 2011 |
| Which Drugs are the Most Innovative? (link) | Guest blog written by Barbara for 2020health think tank. | November 2010 |
| Nice Move on Drug Pricing but Where Next? (link) | Guest blog written by Barbara for 2020health think tank. | November 2010 |
| Liberating the NHS Revisited (link) |
Blog written by Barbara for 2020health think tank. | October 2010 |
| Liberating the NHS: Transparency in outcomes- a framework for the NHS (link) | Submission to Department of Health in response to White Paper. | October 2010 |
| NATIONAL HEALTH SERVICE COMMENTS re. Liberating the NHS: Commissioning for Patients (link) | Submission to Department of Health in response to White Paper. | October 2010 |
| Comments Re. Equity & Excellence: Liberating the NHS (link) | Submission to Department of Health in response to White Paper. A short summary can be viewed here | September 2010 |
| What Women Want: A Manifesto For Health 2010 (link) | Wide-ranging publication with articles from 17 women with healthcare expertise. Compiled by 2020health think tank. | March 2010. Barbara’s article pages 9-12. |
Investment Advisory
· Co-editor of over a hundred issues of Health & Household Investors’ Brief, a publication for professional investors in pharmaceutical and healthcare securities, between 1984 and 1996. The publication was produced by the same team successively at three stockbroking firms: Greenwell, Kleinwort Benson Securities and Robert Fleming Securities.
· An author of numerous investment reports on pharmaceutical and healthcare companies and on the industry between 1984 and 1996.
· Her investment advisory work prior to 1996 was widely quoted in the national press in the UK and USA, as was usual at the time for leading investment analysts covering international business sectors.
Academic Research Published in Medical Journals
· Arzymanow BJ & Kemplay SK (1981) Change with age in the motor endplate in the sternocostalis muscle in the rat. Journal of Anatomy 132: 468
· Arzymanow BJ, Hayes BP & Webster KE (1981) Midbrain neurons outside the isthmo-optic nucleus projecting to the eye in adult birds. Journal of Anatomy 133: 650
· Webster KE, Arzymanow BJ, O’Hara PT & Lieberman AR (1981) Transneuronal labelling of the visual portion of the thalamic reticular nucleus in the rat. Journal of Anatomy 133: 652
· Arzymanow BJ, Gonzalo A & Lieberman AR (1983) Interneurons in the dorsal lateral geniculate nucleus (LGd) of the rabbit. Journal of Physiology 340: 47P
· Jeffery G, Arzymanow BJ & Lieberman AR (1983) Does the early exuberant retinal projections to the superior colliculus in the neonatal rat develop synaptic connections. Developmental Brain Research 14: 135-138
· Gonzalo A, Arzymanow BJ & Lieberman AR (1985) Primary optic projections in the rabbit. Study using the horseradish peroxidise anterograde labelling technique. Revista Española de Fisiología 41: 161-170